Search the web
Sign In
New User? Sign Up
PozHealth
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Want to share photos of your group with the world? Add a group photo to Flickr.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Messages 11724 - 11753 of 31307   Newest  |  < Newer  |  Older >  |  Oldest
Messages: Show Message Summaries   (Group by Topic) Sort by Date v  
#11753 From: ray sex <bronxbomberxxx@...>
Date: Sun May 1, 2005 1:42 pm
Subject: RE: Injecting Bioalcamid in Pasadena?
bronxbomberxxx
Offline Offline
Send Email Send Email
 
Michael, your statement is incorrect there are
doctor's who have been performing "Bio-Alcamid"
injection in the good USA as a off label use just like
"New-Fill" now called "Sculptra" after recently FDA
approved.
When I had "Newfill"/"Sculptra" performed it was
illegal in the USA for use to correct
lipodystrophy/facialwasting. I had only paid a total
of $750 for 2 vials including doctor/office fee's
then. I can certainly confirm that I had recieved my
Bio-Alcamid in NYC, USA.

--- Michael Mooney SuperNutrition
<mmooney@...> wrote:
> No one in the US offers BioAlcamid. Schwartz is just
> good at taking it out.
>
> Michael Mooney

__________________________________________________
Do You Yahoo!?
Tired of spam?  Yahoo! Mail has the best spam protection around
http://mail.yahoo.com

#11752 From: PozHealth@yahoogroups.com
Date: Sun May 1, 2005 2:24 am
Subject: New file uploaded to PozHealth
PozHealth@yahoogroups.com
Send Email Send Email
 
Hello,

This email message is a notification to let you know that
a file has been uploaded to the Files area of the PozHealth
group.

   File        : /xtreme2.pdf
   Uploaded by : nelsonvergel <nelsonvergel@...>
   Description : Lecture in DC June 8th

You can access this file at the URL:
http://groups.yahoo.com/group/PozHealth/files/xtreme2.pdf

To learn more about file sharing for your group, please visit:
http://help.yahoo.com/help/us/groups/files

Regards,

nelsonvergel <nelsonvergel@...>

#11751 From: <m.muaddib@...>
Date: Sat Apr 30, 2005 9:20 pm
Subject: RE: Sexual Anxiety
m.muaddib@...
Send Email Send Email
 
Hey Christopher,
 
I am in the same situation except we have been together 25 years, the last 15 of which I have been poz. Unfortunately I can't offer any help. You are actually doing better than we are. Sadly, we have morphed into no sex and no foreplay for the last 12 years. I, too, would be interested in others' experiences in overcoming this dilemma. As deprssed as I have been over my own infection, I don't think I would be able to handle infecting him, too.
 

Dennis of Los Angeles

m.muaddib@...

 


From: PozHealth@yahoogroups.com [mailto:PozHealth@yahoogroups.com] On Behalf Of Christopher
Sent: Friday, April 29, 2005 7:21 PM
To: PozHealth@yahoogroups.com
Subject: [PozHealth] Sexual Anxiety

I am in a serodiscordant relationship of ten years.  Throughout the
relationship I have had anxiety about infecting my parter when we're
having sex.  In the beginning, we didn't have anal intercourse at all
(on my insistance) for fear I would infect him.  Over the years, I've
gotten more relaxed, and we do anal intercourse now.  But the anxiety
is still there, which often causes me to go limp.  Has anyone had
experience with overcoming this type of anxiety?

Thanks.
Christopher


#11750 From: "Bill Gaul" <wgaul1@...>
Date: Sat Apr 30, 2005 9:06 pm
Subject: Re: triglycerides
upstatedv8
Offline Offline
Send Email Send Email
 
Hi Rachel -
 
I didn't answer this right away because I was due for new lab results. I take Carnitor (which is L-Carnitine), and my triglycerides are down considerably from before I began it. I can't say whether it's a direct result of the Carnitor or something else I'm doing. I also notice a bit more energy and better cognitive function. I haven't stopped the supplement for long enough to tell whether I'd lose these positive changes, but it may very well be a good addition to my regimen from what I can see. I hadn't even thought of it lowering triglycerides. That would be a big plus! (It's also covered by Medicaid in NY)
 
BG
 
Hello everyone,
    I was doing some more research on triglycerides and I noticed that one Nelson's www.medibolics.com website that there was an article on L-Carnitine lowering triglycerides significantly. Has anyone here tried this and did it work for you? Also, did you use L-Carnitine, L-acetyl-carnitine or Carnitor? I'm thinking of giving it a try because of its safety profile.
 
Rachel



#11749 From: "camden_orgain" <porgain@...>
Date: Sat Apr 30, 2005 8:25 pm
Subject: Response to RAMB46@... re T-20 and Phillip in NYC re facial wasting
camden_orgain
Offline Offline
Send Email Send Email
 
Hi Ron,
   I just started T-20 a little over a month ago.  I also am resistant
to everything and have no body fat. I had very bad injection site
reactions, esp. when using the belly. Now I have found a number of
places that don't seem to have as bad a reaction, sometimes none at
all. I don't know if this is my body's response changing, or the
injection sites alone being responsible.  I get my partner to inject
in loose skin area on the back where I can't reach.  I use a clothes
pin to pinch up skin on my arm.  I have found the skin on the thigh
between the inner thigh and the quadriceps, while not very loose, the
injections disperse very nicely here, but not on top of the
quadriceps. I think dispersal is the key to lessen the reactions.  I
use a vibrator, but also manually do long strokes to move the T-20
away from the injection site.  The skin around my abdomen doesn't
want to disperse, so lumps remain and become very inflamed.
   I am on AZT, Truvada, Kaletra and a CCR5 study drug (or placebo).
I have been having some minor problems which may be from my immune
system reconstituting itself.  My viral load was down to 400 from
over 300,000, but high blood levels of LDH, which indicates
inflammation.  So I had to have a gallium scan in case there was some
infection or lymphoma happening.  Luckily, the scan was negative.
   On a different subject, my partner and I are going to Brazil for
three weeks.  We are going for PMMA (metacril) injections for facial
wasting to Dr. Marcio Serra. I only need a touch-up, the last visit
he used NuFill. A posting from Phillip in NYC earlier this week gave
a thorough and enthusiastic review of Dr. Serra and the procedure.  I
spent 6 winters in Brazil and three of those years I went to see Dr.
Serra (2001,2002, and 2003), as recommended by my dermatologist in
NYC (Dr. Patrick Henessey).  Before I saw Dr. Serra, I had
consultations with the head of the Plastic Surgery Board (a friend's
doctor), also with Dr. Ivo Pitanguy (a household name in plastic
surgery in the 1960's) and a "Clinica de Belezza" that had people who
wore white coats, but weren't really doctors. These latter 2 only
offered Restylane, which doesn't last in people with HIV.
    Dr. Serra is a wonderful guy, and quite expert at this procedure.
I believe he pretty much pioneered the use of Metacril, and
documented each patient with photos before and after. Dr. Henessey in
NYC met him at a conference where Dr. Serra was a presenter. He only
charged $300 back then, which was almost pro-bono, so now it is
$500.  Nevertheless, this is an incredible bargain compared with the
procedures done here that I imagine start at around $4500.  People
think Brazil is a third world country, but Rio is totally modern, and
my experience with the doctors there (considerable over the 6 years I
went there) is that they are as good as here, with some outstanding.
They also haven't lost touch with practicing medicine to help people,
not just make money.  All of my doctors there speak English fluently
and studied in the US or France. This is all part of a trend of
outsourcing, with people traveling to India for hip replacements,
Canada for Lasik, etc.

#11748 From: Averageguykc@...
Date: Sat Apr 30, 2005 7:11 pm
Subject: Re: Fuzeon question?
nicetostrangers
Offline Offline
Send Email Send Email
 
I also do my upper arms and find the reactions to be much less painful.  And when I don't have someone around I use a chip clip to hold the skin up just enough so I'm not hitting a muscle. 
 
-----Original Message-----
From: Allan <allan2947@...>
To: RAMB46@...; pozhealth@yahoogroups.com
Sent: Fri, 29 Apr 2005 09:45:19 -0700
Subject: Re: [PozHealth] Fuzeon question?

Ron,
I’ve been on Fuzeon since November 2003.

Although there are techniques that help lessen the injection site reactions (ISR), almost everyone who takes Fuzeon does get them. The reactions aren’t caused by doing the injections incorrectly, but rather from the Fuzeon itself.

The only advice I can give you is to avoid injecting into muscle, massage the injection site after each injection, and rotate injection sites. I recently discovered that I could inject myself in my upper arms by doing a shallow injection in areas that have just a little bit of a fat pad. This helps provide some relief for my thighs and abdomen. If you have someone who can help you with the injections, that would be good for injecting in places that you can’t reach by yourself.

Best of luck to you.

Allan



On 4/29/05 6:41 AM, "RAMB46@..." <RAMB46@...> wrote:

Good morning everyone,
  I will be starting a new regimen on Monday May 1st.
I will be on : Reyataz, Norvir, Truvada, & Fuzeon.
 I do not have any body fat, & I  know the Fuzeon causes injection site reactions.
Does anyone have some tips that will help when you are injecting Fuzeon ?
 I am really concerned how to TRY to help avoid problems ,if possible.
 I have become resistent to all classes of meds, except ' PI's & Tenofovir, this is why I have to start with Fuzeon & PI's.
 Hope someone is on this type of HAART, & can help me out.
Does Reyataz also cause Lipodystrophy ?
 I already have a lot of visceral fat in my abdomen, & hope this does not get worse.
Any information would greatly be appreciated,
         Thanks,
 
Ron
New England, Ma.



Welcome to our PozHealth group!
If you received this email from someone who forwarded it to you and would like to join this group, send a blank email to PozHealth-subscribe@yahoogroups.com and you will get an email with instructions to follow. You can chose to receive single emails or a daily digest (collection of emails). You can post pictures, images, attach files and search by keyword old postings in the group.

For those of you who are members already and want to switch from single emails to digest or vice versa, visit www.yahoogroups.com, click on PozHealth, then on "edit my membership" and go down to your selection. The list administrator does not process any requests, so this is a do-it-yourself easy process ! :)
Thanks for joining. You will learn and share a lot in this group!

NOTE: I moderate, approve or disapprove emails before they are posted. Please follow the guidelines shown in the homepage. I will not allow rudeness, sexually  explicit material, attacks, and anyone who does not follow the rules. If you are not OK with this, please do not join the group.

Forward this email to anyone who may benefit from this information! Thanks!
In Health,

Nelson Vergel (PoWeRTX@...)
List Founder and Moderator




Yahoo! Groups Links


#11747 From: "Bill Gaul" <wgaul1@...>
Date: Sat Apr 30, 2005 5:17 pm
Subject: Re: i have never had allergies,
upstatedv8
Offline Offline
Send Email Send Email
 
Also - Any change in your environment could be a culprit.My last apartment
had a forced air heating and AC system, and I sneezed so much I actually
threw my back out once. Then I moved to my present place with baseboard
heat, and the chronic sinus problems disappeared - AND I have a cat now! I'm
guessing mold. It's also true that some people develop allergies
unexpectedly as we get older, as JB said.

BG

----- Original Message -----
From: "John Barrow" <pozbod@...>
To: <PozHealth@yahoogroups.com>
Sent: Friday, April 29, 2005 10:02 AM
Subject: [PozHealth] i have never had allergies,


Don,

It does sound very much like allergies.  Have you had any changes in T
cells, up or down in the last few months?  Sometimes, improving immune
function leads to allergic manefestations you didn't have before.
Allergies also tend to increase with age, and we're getting older......

JB
On Apr 29, 2005, at 9:44 AM, PozHealth@yahoogroups.com wrote:

> i have never had allergies,
> but i imagine this is what they would be like.  i have seen an eye
> doctor but
> they have nothing specific to say about this and i never thought to
> mention the
> medication change.  anyways, i have tried to figure out what could be
> happening as nothing has changed in my medical/medication life other
> than that small
> change in med formulation.  it is a puzzle.  could it be HIV related?
> that
> seems weird, but i guess the second name of this disease is "weird".

#11746 From: PoWeRTX@...
Date: Sat Apr 30, 2005 12:26 pm
Subject: Re: connection between sugar and diarrhea?
nelsonvergel
Offline Offline
Send Email Send Email
 
In a message dated 4/30/2005 11:22:45 AM Central Standard Time, jim98122x@... writes:
I seem to recall reading somewhere that eating foods or drinking
beverages high in sugar can aggravate diarrhea.  Is that true?

Like many people, Protease Inhibitors make me very lactose intolerant.
   So already I have to keep vigilant to keep the dirrhea in check.
I'm wondering if sugar is also a problem, especially sweetened drinks?


 Yes, definitely...stay away from anythiing that  has fructose and sugar if you have diarrhea. Avoid milk products, apple juice, and most bottled juices and soft drinks. Minimize insoluble fiber also.  Pedialite (it is made for kids) is one of the best drinks to hydrate.
 
Taking calcium carbonate pills,(1000 mg twice a day) and acidophilus helps
 me a lot (Glutamine at 30 grams a day also does wonders)
 
*******************
I am transitioning to a new email : nvergel@...
so please feel free to answer to this one if you are having problems with my AOL email. Thanks!


Nelson Vergel
Director
Program for Wellness Restoration, PoWeR
A 501 (c) 3 non profit national organization
powerusa.org
salvagetherapies.org
faciawasting.org


Disclaimer

This information (and any accompanying printed material) is not intended to replace the attention or advice of a physician or other health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a qualified health care professional.

#11745 From: John Barrow <pozbod@...>
Date: Sat Apr 30, 2005 2:36 pm
Subject: I will be starting a new regimen on Monday May 1st.
johnftl59
Offline Offline
Send Email Send Email
 
Good morning, Ron.

Reyataz causes fewer lipid abnormalities in the blood, which makes you
think ultimately that it might screw up body fat less.
Norvir causes blood lipid problems, but you'll be taking it at a fairly
low dose.  Do watch your cholesterol and triglycerides, and stay on top
of those numbers.

Fuzeon site reactions can be a problem, but most of the guys I know who
take it find it surprisingly tolerable.......and effective.

Truvada seems pretty good for lipid problems, but you doctor will need
to watch for kidney issues.

JB
On Apr 30, 2005, at 9:12 AM, PozHealth@yahoogroups.com wrote:
>
>   I will be starting a new regimen on Monday May 1st.
> I will be on : Reyataz, Norvir, Truvada, & Fuzeon.
>  I do not have any body fat, & I  know the Fuzeon causes  injection
> site
> reactions.
> Does anyone have some tips that will help when you are injecting
> Fuzeon  ?
>  I am really concerned how to TRY to help avoid problems ,if  possible.
>  I have become resistent to all classes of meds, except ' PI's &
> Tenofovir,
> this is why I have to start with Fuzeon & PI's.
>  Hope someone is on this type of HAART, & can help me out.
> Does Reyataz also cause Lipodystrophy ?
>  I already have a lot of visceral fat in my abdomen, & hope this  does
> not
> get worse.
> Any information would greatly be appreciated,
>          Thanks,

#11744 From: "Christopher" <brightdba2004@...>
Date: Sat Apr 30, 2005 3:20 am
Subject: Sexual Anxiety
brightdba2004
Offline Offline
Send Email Send Email
 
I am in a serodiscordant relationship of ten years.  Throughout the
relationship I have had anxiety about infecting my parter when we're
having sex.  In the beginning, we didn't have anal intercourse at all
(on my insistance) for fear I would infect him.  Over the years, I've
gotten more relaxed, and we do anal intercourse now.  But the anxiety
is still there, which often causes me to go limp.  Has anyone had
experience with overcoming this type of anxiety?

Thanks.
Christopher

#11743 From: JuLev@...
Date: Sat Apr 30, 2005 9:10 am
Subject: NATAP: Once Daily Kaletra is FDA Approved....
JuLev@...
Send Email Send Email
 
NATAP - http://www.natap.org

FDA Approves Once Daily Kaletra For Therapy Naïve Patients

This report combines information from both the FDA statement & the Abbott Press Release. The antiviral effect of once daily (QD) & twice daily (BID) were similar in the study (Study #418) comparing the two dose regimens as you can see in the Table below (71% qd vs 65% bid, <LLQ); the once daily regimen was associated with higher rates of diarrhea; and the once daily regimen is approved by the FDA for therapy naïve patients & not for therapy experienced patients because as the FDA says trough concentrations are 60% lower for the qd regimen & because there are no studies of the once daily regimen in treatment-experienced patients. Jules Levin

ABBOTT RECEIVES FDA APPROVAL FOR A ONCE-DAILY KALETRA  BASED (LOPINAVIR/RITONAVIR) TREATMENT REGIMEN

ABBOTT PARK, Ill., May 2, 2005 - Abbott announced today that it received U.S. Food and Drug Administration (FDA) approval to market a once-daily dosing regimen for Kaletra (lopinavir/ritonavir), a protease inhibitor used in combination with other anti-HIV medications, for the initial treatment of HIV. The new dosing regimen for Kaletra offers physicians and patients increased flexibility in managing their individual HIV treatment without sacrificing the proven efficacy of the twice-daily dosing option, in patients new to HIV therapy. This new dosing option is available in both liquid and soft gel capsule formulations.

Approval for the new regimen is based on data from a clinical study conducted in 190 patients new to HIV therapy which evaluated the effectiveness of the once-daily and twice-daily Kaletra doses, both administered in combination with once-daily tenofovir and emtricitabine, over a period of 48 weeks. Results demonstrated comparable virologic responses (HIV RNA less than 50 copies per milliliter) between the once- and twice-daily dosing groups. Kaletra once-daily was generally well tolerated (SEE STUDY DATA BELOW). In both the once-daily and twice-daily arms, the most frequent drug-related adverse events of moderate or greater intensity reported were diarrhea and nausea, although diarrhea was observed more frequently in the once-daily arm.

Particular caution should be used when taking Viagra, Cialis or Levitra since the interaction with Kaletra may result in an increase in their related side effects. Patients should discuss all medicines, including those without a prescription and herbal preparations that they are taking or plan to take with their physician or pharmacist.

Once-daily Kaletra should not be administered in combination with Sustiva, Viramune, Agenerase, Viracept, Tefretol, Phenobarbitol and Dilantin.

FDA STATEMENT
FDA today approved the use of KALETRA 800/200mg once-daily administration for the treatment of HIV-infection in therapy-naïve adult patients, based on review and analysis of two clinical trials comparing safety and efficacy of lopinavir (LPV)/ritonavir (RTV) 800/200 mg once daily (qd) and LPV/RTV 400/100 mg twice daily (bid), for a duration of at least 48 weeks in antiretroviral-naïve HIV-1 infected subjects.

At this time, once daily Kaletra is not approved for treatment experienced patients because trough concentrations of lopinavir are approximately 60% than that observed in the twice-daily regimen and because there are no clinical studies comparing the two dosing schedules in treatment-experienced individuals.

The following is a summary of the labeling changes-

CLINICAL PHARMACOLOGY:
Pharmacokinetic data for Kaletra given as 800/200 mg once daily in HIV-1 infected antiretroviral naïve adult subjects were added.

Specifically, the following text was included.

The pharmacokinetics of once daily KALETRA have been evaluated in HIV-infected subjects naïve to antiretroviral treatment. KALETRA 800/200 mg was administered in combination with emtricitabine 200 mg and tenofovir 300 mg as part of a once daily regimen.

Multiple dosing of 800/200 mg KALETRA QD for 4 weeks with food (n=24) produced a mean + SD lopinavir peak plasma concentration (Cmax) of 11.8 + 3.7
μg/mL, occurring approximately 6 hours after administration.

The mean steady-state trough concentration prior to the morning dose was 3.2 + 2.1
μg/mL and minimum concentration within a dosing interval was 1.7 + 1.6 μg/mL. Lopinavir AUC over a 24 hour dosing interval averaged 154.1 + 361.4 μg *h/mL

A statement that KALETRA once daily has not been evaluated in pediatric patients was included.

INDICATIONS AND USAGE:

The following information was added:

Once-daily administration of KALETRA is not recommended in therapy-experienced patients.

When initiating treatment with KALETRA in therapy-naïve patients, it should be noted that the incidence of diarrhea was greater for KALETRA once daily compared to KALETRA twice daily in Study 418 (57% vs 35% - events of all grades and probably or possibly related to drug: 16% vs 5% - events of at least moderate severity and probably or possibly related to drug).

Description of Clinical Studies

Results from study M02-418 were included as follows.

Study 418: KALETRA QD + tenofovir DF + emtricitabine compared to KALTERA BID + tenofovir DF + emtricitabine

Study 418 is an ongoing, randomized, open-label, multicenter trial comparing treatment with KALETRA 800/200 mg QD plus tenofovir DF and emtricitabine versus KALETRA 400/100 mg BID plus tenofovir DF and emtricitabine in 190 antiretroviral treatment naïve patients.

Patients had a mean age of 39 years (range: 19 to 75), 54% were Caucasian and 78% were male. Mean baseline CD4 cell count was 260 cells/mm3 (range 3 to 1006 cells/mm3) and mean baseline plasma HIV RNA was 4.8 log10 copies/mL (range: 2.6 to 6.4 log10 copies/mL).

Treatment response and outcomes of randomized treatment are presented in Table 6:

                               
Kaletra QD          Kaletra BID
                               +TDF/FTC            +TDF/FTC
                                 n=115                    n=75
Responder                  71%                      65%
-Total viral
failure                         10%                         9%
-Rebound                      6%                         5%
-Never suppressed
(thru wk 48)                 3%                          4%
-death                           0%                         1%
-Disct due to
Adverse event           12%                         7%
Other                          9%                         19%


PRECAUTIONS
In this section,
Table 10:
Established and Other Potentially Significant Drug Interactions: Alteration in Dose or Regimen May Be Recommended Based on Drug Interaction Studies or Predicted

Interaction was revised to include information that-

KALETRA should not be administered once daily in combination with efavirenz, nevirapine, amprenavir, nelfinavir, carbamazepine, phenobarbital, or phenytoin. In addition, statements that KALETRA once daily has not been studied in combination with indinavir or saquinavir was included.

ADVERSE REACTIONS:
The adverse reaction profile and laboratory abnormalities observed in the Kaletra once daily study were included in this section.

DOSAGE AND ADMINISTRATION

This section was modified to include dosing instructions for therapy-naïve and therapy-experienced patients as follows:

Adults:

Therapy-Naïve Patients
~       KALETRA 400/100 mg (3 capsules or 5.0 mL) twice daily taken with food
~       KALETRA 800/200 mg (6 capsules or 10 mL) once daily taken with food


Therapy-Experienced Patients
~       KALETRA 400/100 mg (3 capsules or 5.0 mL) twice daily taken with food


Once-daily administration of KALETRA is not recommended in therapy-experienced patients

In addition, the following statements were added:

KALETRA should not be administered as a once-daily regimen in combination with efavirenz, nevirapine, amprenavir or nelfinavir.
KALETRA once daily has not been evaluated in pediatric patients.

KALTERA is manufactured by Abbott Laboratories, North Chicago, IL.

Richard Klein
Office of Special Health Issues
Food and Drug Administration

Kimberly Struble
Division of Antiviral Drug Products
Food and Drug Administration




#11742 From: "Michael Mooney SuperNutrition" <mmooney@...>
Date: Sat Apr 30, 2005 10:56 am
Subject: RE: Injecting Bioalcamid in Pasadena?
medibolicsmike
Offline Offline
Send Email Send Email
 
No one in the US offers BioAlcamid. Schwartz is just good at taking it out.
 
Michael Mooney


From: hijung@... [mailto:hijung@...]
Sent: Saturday, April 30, 2005 2:18 AM
To: mmooney@...
Subject: RE: [PozHealth] Injecting Bioalcamid in Pasadena?

Anyone know if Dr. Shwartz offers Bio Alcamid? I'm about to go to Mexico for it but Id rather not. For the record I'm a post Sydney Coleman fat graft disaster patient. He made me grossly asymmetrical and I need Bio Alcamid to even them out.





--- On Thu 04/28, Michael Mooney SuperNutrition < mmooney@... > wrote:
From: Michael Mooney SuperNutrition [mailto: mmooney@...]
To: PozHealth@yahoogroups.com
Date: Thu, 28 Apr 2005 00:43:15 -0700
Subject: [PozHealth] Removing Bioalcamid in Pasadena


I have had another friend have BioAlcamid taken from his face by Dr. Michael
Schwartz of Pasadena.

This one had about 14 cc's taken out.

He was severely wasted before the BioAlcamid was put in but was convinced
that although he looked much better with the BioAlcamid, his face was far
too full, and looked abnormally round.

Dr. Schwartz used liposuction and squeezing to remove it.

Michael Mooney
www.medibolics.com
http://www.powerusa.org/






------------------------ Yahoo! Groups Sponsor --------------------~-->
What would our lives be like without music, dance, and theater?
Donate or volunteer in the arts today at Network for Good!
http://us.click.yahoo.com/CybhMB/SOnJAA/xGEGAA/WzSolB/TM
--------------------------------------------------------------------~->

Welcome to our PozHealth group!
If you received this email from someone who forwarded it to you and would like to join this group, send a blank email to PozHealth-subscribe@yahoogroups.com and you will get an email with instructions to follow. You can chose to receive single emails or a daily digest (collection of emails). You can post pictures, images, attach files and search by keyword old postings in the group.

For those of you who are members already and want to switch from single emails to digest or vice versa, visit www.yahoogroups.com, click on PozHealth, then on "edit my membership" and go down to your selection. The list administrator does not process any requests, so this is a do-it-yourself easy process ! :)
Thanks for joining. You will learn and share a lot in this group!

NOTE: I moderate, approve or disapprove emails before they are posted. Please follow the guidelines shown in the homepage. I will not allow rudeness, sexually explicit material, attacks, and anyone who does not follow the rules. If you are not OK with this, please do not join the group.

Forward this email to anyone who may benefit from this information! Thanks!
In Health,

Nelson Vergel (PoWeRTX@...)
List Founder and Moderator

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/PozHealth/

<*> To unsubscribe from this group, send an email to:
PozHealth-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/







#11741 From: "jim98122x" <jim98122x@...>
Date: Sat Apr 30, 2005 2:41 am
Subject: connection between sugar and diarrhea?
jim98122x
Offline Offline
Send Email Send Email
 
I seem to recall reading somewhere that eating foods or drinking
beverages high in sugar can aggravate diarrhea.  Is that true?

Like many people, Protease Inhibitors make me very lactose intolerant.
    So already I have to keep vigilant to keep the dirrhea in check.
I'm wondering if sugar is also a problem, especially sweetened drinks?

#11740 From: "Joe" <joseph.denney@...>
Date: Sat Apr 30, 2005 12:46 am
Subject: Re: A problem of my thin skin
bigeight_98
Offline Offline
Send Email Send Email
 
Hey guys,

I tried replying to this post earlier, but didn't realize Yahoo has
changed the posting procedure, so I guess my reply just went to
thadd1.  Take a look at Dr. Perricone's book, The Perricone
Prescription.  In it (on pages 115-116) he writes about an elderly
man with the same problem, due to years of sun damage.  He
prescribed a cream containing vitamin C ester at a 10 percent level
in a moisturizing base, to be applied to the patient's entire body
once daily, and to problem areas twice daily.  The man started
noticing results within ten weeks, and within three months the
problem had basically disappeared.  Dr. Perricone mentions that he
had a compounding pharmacist make up one pound jars of this cream --
perhaps you can get your doctor to prescribe the same thing.  Hope
this helps.

Joe

--- In PozHealth@yahoogroups.com, thadd1@a... wrote:
> Hey folks;
> Every time I bump into something...yes, I am kinda clumsy, my skin
rips and
> I bleed.
> Even my arms have this problem...when I work in the yard or work
out at the
> gym every third time I find I am bleeding from a simple bump.
>
> I am on Sustiva, 3TC  and Viread with androgel.  That is my whole
regime.  I
> also take a vitamin from GNC.
>
> Viral load is undetectable and my CD4's are around 600.
>
> Any suggestions? on making my skin thicker?
>
> Thad

#11739 From: "Christopher" <brightdba2004@...>
Date: Fri Apr 29, 2005 10:25 pm
Subject: Re: anyone with bad results from Sculptra/Newfill?
brightdba2004
Offline Offline
Send Email Send Email
 
yes, Charlie, I got free Sculptra and I have Medicare.


--- In PozHealth@yahoogroups.com, WEBcfm@a... wrote:
> Hi ..
> I just want to thank everyone for all of the replies to my posting
about
> Sculptra injections.  All of the positive feedback gave me a great
attitude, and
> the courage to see a plastic surgeon yesterday.  He was extremely
nice, not to
> mention, young and cute lol!  I'm going to send out the form for
the free kits
> of Sculptra today.  The one thing I just noticed though, was that
the patient
> shouldn't have Medicare/medicaid coverage that could pay for the
Sculptra.  I
> have both of those insurances, but I doubt that they would cover
the cost of
> the Sculptra.  Has anyone else gotten the free Sculptra kits while
also
> covered by either or both of these insurance plans?
> By the way, I'm going to a dinner tomorrow night..and the speaker
is Nelson
> Vergel!  I'm looking forward to hearing what he has to say, and
actually seeing
> him in person.
> Thanks again to all that have taken the time to reply to my
posting.
> Charlie in Connecticut

#11738 From: edlortz@...
Date: Fri Apr 29, 2005 12:51 pm
Subject: Re: Help me to be a better nurse
edlortz
Offline Offline
Send Email Send Email
 
Hi CC
    Tell them that the first priority for a patient is to get well from the current problem. That requires taking meds, being proactive, tell the caregivers exactly what the problem is, what reactions they are having. Don't hesistate to voice a concern if something doesn't feel right, whether it being a part of your body or if you are concerned about the medical profession's course of action.
    The next thing is to prepare the patient for a long life. This also requires being proactive, but also controlling one's life. Manage stress, but stay challenged. Reduce as much as possible the problems with job, money, living situation. Prepare long range solutions to problems. Stay with meds, avoid drugs (the recreational kind), and exercise regularly and eat right, or as close to it as possible. You probably can't tell your nurses this, but if the patient doesn't like their doc, change docs. I've "fired" two primary, two proctologists, and three dermatologists, before i got to my current team, all of whom i've had over five years each.
    Basically, help them thru the current problem and get them thinking long term. I'm 61, been poz for 22 years, undetectable, and with 500 t's, and never been hospitalized with an OI (knock on a VERY LARGE piece of wood).
 
        cheers
            edward

#11737 From: Michael Dorosh <orbit38@...>
Date: Fri Apr 29, 2005 4:25 pm
Subject: Re: Help me to be a better nurse
mdorbit38
Offline Offline
Send Email Send Email
 
Many public (and/or Ryan White funded) clinics have budget problems and sometimes patients continually see a nurse or PA.  Please make sure your patients know that they always have the right to see their doctor if they want to.
 
On Thu, 28 Apr 2005 17:48:44 -0000 "C Collins" <skibabet@...> writes:
Hi. My name is CC and I am a nursing student due to graduate in August.
As part of this semester I am to give a presentation on HIV.  I would
like to
focus on "how to be a better nurse to the HIV patient.".  Is there
anything you would like to tell a graduating group of nurses? Any of
your thoughts or advice is greatly appreciated! My project is due
05/02/05 so an immediate response would be much obliged!
Please email me at  skibabet@...











Welcome to our PozHealth group!
If you received this email from someone who forwarded it to you and would like to join this group, send a blank email to PozHealth-subscribe@yahoogroups.com and you will get an email with instructions to follow. You can chose to receive single emails or a daily digest (collection of emails). You can post pictures, images, attach files and search by keyword old postings in the group.

For those of you who are members already and want to switch from single emails to digest or vice versa, visit www.yahoogroups.com, click on PozHealth, then on "edit my membership" and go down to your selection. The list administrator does not process any requests, so this is a do-it-yourself easy process ! :)
Thanks for joining. You will learn and share a lot in this group!

NOTE: I moderate, approve or disapprove emails before they are posted. Please follow the guidelines shown in the homepage. I will not allow rudeness, sexually  explicit material, attacks, and anyone who does not follow the rules. If you are not OK with this, please do not join the group.

Forward this email to anyone who may benefit from this information! Thanks!
In Health,

Nelson Vergel (PoWeRTX@...)
List Founder and Moderator


 

orbit38@...
303-777-5737

#11736 From: <frankjacks@...>
Date: Fri Apr 29, 2005 3:53 pm
Subject: RE: Vitamin C does not cause kidney stones
frankcjackson
Offline Offline
Send Email Send Email
 

You appear to be right, though when I first learned this just a few years ago, they thought it was true. If you want to read the whole article go to the page for the Linus Pauling Institute at Oregon State University (http://lpi.oregonstate.edu/f-w99/kidneystones.html).

 

However, the last sentence of the article states: “In particular, the concern about the role of vitamin C in kidney stone formation, a source of speculation for several decades, appears to be no longer justified.”

 

My apologies for spreading untruths.

 

Frank

 


From: PozHealth@yahoogroups.com [mailto:PozHealth@yahoogroups.com] On Behalf Of Michael Mooney
Sent: Friday, April 29, 2005 7:14 AM
To: PozHealth@yahoogroups.com
Subject: [PozHealth] Vitamin C does not cause kidney stones

 

Whatever the cause of your kidney stones, it was not Vitamin C.
Studies show reduced kidney stones with more Vitamin C (and B6).

The cause of kidney stones is usually too much oxalic acid in the body, or
too little calcium in the GI tract to bind to oxalic acid to carry it out -
so it does not enter the body. As much as 99 percent of kidney stones can be
calcium oxalate, calcium bonded to oxalic acid. Some studies indicate that
having enough calcium in the diet or via supplementation to reduce oxalic
acid intake can help reduce the potential for kidney stone formation, too.

********************************************************************
Higher Doses of Vitamin C Have Been Shown To Decrease Kidney Stones And
Increase Bone Density

Gerster, H. No contribution of ascorbic acid to renal calcium oxalate
stones. Ann Nutr Metab 1997;41(5):269-282

Comment: For those who are concerned that Vitamin C intake might increase
the risk of kidney stones, this study stated that, "In the large-scale
Harvard Prospective Health Professional Follow-Up Study, those groups in the
highest quintile of Vitamin C intake, above 1,500 mg per day, had a lower
risk of kidney stones than the groups in the lowest quintiles."

Side note:
Vitamin C also increases bone density when enough is taken.

Morton DJ, et al.  Vitamin C supplement use and bone mineral density in
postmenopausal women. J Bone Min Res 2001;16(1):135-140.
Comment: This study showed that senior women who took between 1,000 and
5,000 mg of supplemental Vitamin C per day had approximately 5% greater
spinal bone mineral density than women who took 500 mg or less over three
years. Higher Vitamin C doses were superior to 500 mg per day or less.

Michael Mooney

***********************************************************************

Message: 4        
   Date: Wed, 27 Apr 2005 11:50:43 -0700
   From: <frankjacks@...>
Subject: RE: hEllooooooooooooooooooeveryone

I'd be cautious about heavy-dosing vitamin C. I found out (the hard way)
that it is a major cause of kidney stones, and such pain
you don't want to know. As always, TALK TO YOUR DOCTOR before you do
anything!







Welcome to our PozHealth group!
If you received this email from someone who forwarded it to you and would like to join this group, send a blank email to PozHealth-subscribe@yahoogroups.com and you will get an email with instructions to follow. You can chose to receive single emails or a daily digest (collection of emails). You can post pictures, images, attach files and search by keyword old postings in the group.

For those of you who are members already and want to switch from single emails to digest or vice versa, visit www.yahoogroups.com, click on PozHealth, then on "edit my membership" and go down to your selection. The list administrator does not process any requests, so this is a do-it-yourself easy process ! :)
Thanks for joining. You will learn and share a lot in this group!

NOTE: I moderate, approve or disapprove emails before they are posted. Please follow the guidelines shown in the homepage. I will not allow rudeness, sexually  explicit material, attacks, and anyone who does not follow the rules. If you are not OK with this, please do not join the group.

Forward this email to anyone who may benefit from this information! Thanks!
In Health,

Nelson Vergel (PoWeRTX@...)
List Founder and Moderator




#11735 From: Allan <allan2947@...>
Date: Fri Apr 29, 2005 4:45 pm
Subject: Re: Fuzeon question?
allan2947@...
Send Email Send Email
 
Ron,
I’ve been on Fuzeon since November 2003.

Although there are techniques that help lessen the injection site reactions (ISR), almost everyone who takes Fuzeon does get them. The reactions aren’t caused by doing the injections incorrectly, but rather from the Fuzeon itself.

The only advice I can give you is to avoid injecting into muscle, massage the injection site after each injection, and rotate injection sites. I recently discovered that I could inject myself in my upper arms by doing a shallow injection in areas that have just a little bit of a fat pad. This helps provide some relief for my thighs and abdomen. If you have someone who can help you with the injections, that would be good for injecting in places that you can’t reach by yourself.

Best of luck to you.

Allan



On 4/29/05 6:41 AM, "RAMB46@..." <RAMB46@...> wrote:

Good morning everyone,
  I will be starting a new regimen on Monday May 1st.
I will be on : Reyataz, Norvir, Truvada, & Fuzeon.
 I do not have any body fat, & I  know the Fuzeon causes injection site reactions.
Does anyone have some tips that will help when you are injecting Fuzeon ?
 I am really concerned how to TRY to help avoid problems ,if possible.
 I have become resistent to all classes of meds, except ' PI's & Tenofovir, this is why I have to start with Fuzeon & PI's.
 Hope someone is on this type of HAART, & can help me out.
Does Reyataz also cause Lipodystrophy ?
 I already have a lot of visceral fat in my abdomen, & hope this does not get worse.
Any information would greatly be appreciated,
         Thanks,
 
Ron
New England, Ma.


#11734 From: Michael Dorosh <orbit38@...>
Date: Fri Apr 29, 2005 3:55 pm
Subject: Re: hEllooooooooooooooooooeveryone
mdorbit38
Offline Offline
Send Email Send Email
 
I had major stones and problems a number of years ago and have not taken vitamin C since.  I rely on oranges, tomatoes, etc, and a multi-vitamin for my daily needs, but NOT as an extra supplement.
 
On Wed, 27 Apr 2005 11:50:43 -0700 <frankjacks@...> writes:

I’d be cautious about heavy-dosing vitamin C. I found out (the hard way) that it is a major cause of kidney stones, and such pain you don’t want to know. As always, TALK TO YOUR DOCTOR before you do anything!


#11733 From: JuLev@...
Date: Fri Apr 29, 2005 11:52 am
Subject: NATAP: Diabetes/Lipids Contribute to Liver Disease
JuLev@...
Send Email Send Email
 
NATAP - http://www.natap.org

Diabetes & Lipids Associated with Liver Disease

Reported by Jules Levin

These studies were reported at the 40th annual EASL liver meeting in Paris (April 2005). The studies support numerous previous studies that insulin resistance and diabetes can contribute to advancing liver disease, particularly in people with viral hepatitis C or B. As well, elevated lipids may contribute.

Impact of Overweight & Diabetes on Liver-Related Death in Patients with Alcoholic & Viral Hepatitis C Cirrhosis

G. N'Kontchou1, M. Tin Tin Htar1, J. Paries2, F. Kazemi1, V. Bourcier1, N. Ganne-Carrie1, P. Nahon1, V. Grando-Lemaire1, J.C. Trinchet1, M. Beaugrand1

1 Liver Unit, Jean Verdier Hospital, Bondy, France
2 Public Health Unit, Jean Verdier Hospital, Bondy, France


Obesity and diabetes have been suggested to be risk factors of liver-related death in recent population-based cohort studies. This study was aimed to assess prospectively the impact of these factors on liver-related death (including liver transplantation).

Overweight & diabetes type II are risk factors of cirrhosis in patients with alcoholic & viral HCV. They are also risk factors for liver cancer (hepatocellular carcinoma). Their influence on liver-related death in patients has not yet been evaluated.

A large cohoht of 963 patients with compensated cirrhosis regularly followed for a screening program for HCC were included. All clinical and biological variables were collected at inclusion. Ultrasonography & alfa-feto protein were used for follow-up evaluation. Outcomes evaluated were: liver-related death, liver-related death including liver transplantation (HCC, liver failure, portal hypertension), & occurrence of HCC was also recorded.

Predictive factors for overall and liver-related death were determined by log-rank test and Cox proportional hazards model. Survival to events was estimated by Kaplan-Meier method.

BASELINE CHARACTERISTICS n=963:
Age: 57
63% male
Etiologies: (alcohol/HCV/mixed): 484/322/157
Diabetes: 298 (31%)
BMI (kg/m2): 25/6 +/-4.7
Prothrombine time: 72+/-17
Platelet counts: 137 +/-64
Bilirubin: 28 mmol/l
Albumin (g/l): 39+/-6
AST (N): 2
ALT (N): 2
AP (N): 1.4
y-GT (N): 3.9

Results
-There were 484 alcoholic cirrhosis, 322 HCV, 157 HCV+alcohol.
-Mean age was 57.2±11 yr and mean BMI was 25.6 kg/m2.
-607 were male patients.
-298 patients were diabetic.
-After a mean follow-up of 66.7±45.2 months, 384 patients died, of which 279 were liver-related deaths (liver failure: 142; hepatocellular carcinoma: 117; portal hypertension: 20).

In univariate analysis, factors associated with liver-related death were:
--BMI e27.5 [OR 1.9; 1.5-2.4; p < 0.0001]
--age >57 yr [OR 1.6; 1.3-2.0; p < 0.0001]
--male sex [1.7; 1.3-2.1; p < 0.0001]
--platelet count <140,000/mm3 [OR 1.9; 1.5-2.5; <0.0001]
--serum albumin <42 g/l [2.8; 2.0-3.9; p < 0.0001]
--prothrombin activity <82% [2.3; 1.7-3.1; p < 0.0001]
--alkaline phosphatase >1.4 ULN [OR 1.9; 1.5-2.4; p < 0.0001]
--total bilirubin >17 mm/ml [OR 1.9; 1.5-2.4, p < 0.0001].

Diabetes was not significantly related.

In multivariate analysis, independent risk factors for liver-related death were:
--serum albumin <42 g/l [OR 2.00; 1.4-2.9; p = 0.0004]
--BMI
e27.5: [OR 1.8; 1.4-2.4; p < 0.0001]
--age >57 yr [OR 1.7; 1.3-2.3; p = 0.0002]
--male sex [OR 1.5; 1.1-2.1; p = 0.01]
--prothrombin activity <82% [OR 1.6; 1.1-2.2 p = 0.02]
--alkaline phosphatase >1.4 ULN [OR 1.4; 1.0-1.9; p = 0.03].

These results were confirmed in different etiological subgroups.

Conclusion: Overweight was an independent and important predictive factor of liver-related death in patients with compensated HCV and alcohol cirrhosis.

Diabetes is Strongly Associated with Advanced Fibrosis;
Elevated Lipids May Be Associated with Fibrosis
--Patient Populations with High prevalence of Diabetes, like Hispanics, May Be Particularly At Risk for Advancing Liver Disease

“ASSOCIATION BETWEEN DIABETES, OVERWEIGHT, OBESITY AND DYSLIPIDEMIA WITH FIBROSIS PROGRESSION IN CHRONIC HEPATITIS C PATIENTS”

A. Loaeza-del Castillo, F. Vargas-Vorácková

1 Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición, Mexico
2 Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición, Mexico

Fibrosis progression in chronic hepatitis C (CHC) patients is variable, factors associated with an accelerated progression have been identified, but they do not account for the heterogeneity seen between individuals.

Aim: To determine the prevalence of diabetes, overweight, obesity and dyslipidemia in CHC patients and the association of these metabolic factors with liver fibrosis progression.

Method: Patients with CHC seen in our institution between 1993 and 2003 were retrospectively studied (n = 1618). Patients with a known duration of infection acquired by transfusion with a liver biopsy performed before any antiviral treatment were included. Patients with overt hepatic insufficiency were excluded. The diagnoses of diabetes, overweight, obesity and dyslipidemia were investigated and liver fibrosis stage (METAVIR). Variables were tested for their association with significant fibrosis (F2, F3, F4).

RESULTS
--108 patients were included, 71 (66%) female and 37 (34%) male,
--mean age was 48.7+12.2 years.
--Age at infection was 24.7±13 years, acquired between 1944-2000.
--78% were HCV-genotype 1.
--Fibrosis stage was: F0 = 15 (14%), F1 = 38 (35%), F2 = 9 (8%), F3 = 8 (8%) and F4 = 38 (35%).
--Mean fibrosis progression rate was 0.106±0.101 (0-0.44).
--26 patients (24%) had diabetes, 10 (9%) glucose intolerance, 24 (22%) obesity [body mass index (BMI)
e30 kg/m2] and 49 (45%) overweight (25 d BMI < 30 kg/m2).
--Dyslipidemia was investigated in 75 patients and confirmed in 25 (33.3%). Association between these variables and fibrosis is depicted in the table.

                        

Variable     Odds ratio       95%CI          P   
                        

F2-F4    
Diabetes         3.56         1.35-9.42     0.008
Overweight        1.006        0.47-2.14     0.98 
Obesity         1.18         0.47-2.93     0.71 
Dyslipidemia         0.33         0.13-0.86     0.02 
Cirrhosis    
Diabetes         2.94         1.18-11.9     0.01 
Overweight         0.96         0.43-2.12     0.92 
Obesity         1.48         0.56-3.61     0.45 
Dyslipidemia         0.36         0.12-1.06     0.05 
                        

    
Conclusions: Diabetes is a factor strongly associated with advanced fibrosis and cirrhosis. In populations with a high prevalence of diabetes, such as Hispanics, this association must be taken into account. Lipid metabolism has a specific role in the pathogenesis of CHC and the possible protector role of dyslipidemia for significant liver fibrosis should be investigated in further studies.


“INSULIN RESISTANCE PROMOTES FIBROSIS PROGRESSION AND PREDICTS NECRO-INFLAMMATORY ACTIVITY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE”

D. Sánchez-Muñoz1, E. Suárez1, M.V. Galán1, L. Grande1, G. Muñoz2, M. Romero-Gómez1

1 Hepatology Unit, Hospital Universitario de Valme, Sevilla, Spain
2 Pathology Unit, Hospital Universitario de Valme, Sevilla, Spain


Aims: To assess the presence of metabolic syndrome X (MSx) and insulin resistance (IR), and its relationship with histologic damage, in patients with non-alcoholic fatty liver disease (NAFLD).

Patients and Methods: Thirty-five patients, 25 male and 10 female, with an average age of 45.7±12.7 [24-76] years, diagnosed by NAFLD, were included. Liver biopsy was carried out after persistence for, at least, six months of altered liver enzymes with appropriate diet and physical activity therapies. Histological damage was assessed according to Brunt criteria (Semin Liver Dis 2001; 21: 3-16). Body mass index (BMI) was calculated. MSx was diagnosed according to ATP III criteria. IR was calculated using the HOMA-IR index = [Glucose(mmol/l) _ Insulin(UI/ml)]/22.5.

RESULTS

Only one patient (2.5%) showed normal weight; 17/35 (48.6%) patients showed overweight and 17/35 (48.6%) patients were obese.
--MSx was present in 14/35 (42.5%) patients;
--central obesity in 65.7%,
--high triglyceride levels in 62.9%,
--altered glucose metabolism in 28.6%,
--hypertension in 31.4% and
--low HDL-colesterol levels in 24%.
--IR was present (HOMA-IR >2) in 23/33 (74.3%) patients.
--The histologic diagnosis was simple hepatocyte steatosis (HS) in 8/35 (22.9%) patients and steatohepatitis (NASH) in 27/35 (77.1%) patients: Fibrosis degree was: absent in 13 patients, mild fibrosis (F1-F2) in 6 patients, bridging fibrosis (F3) in 7 patients and cirrhosis (F4) in 1 patient.

Patients with HS showed lower triglyceride levels (99±43 vs 169±85 mg/dl; p = 0.034) and HOMA-IR (2.54±0.9 vs 4.5±2.5; p = 0.002) than patients with NASH.

Triglycerides >180 mg/dl or HOMA IR >4.5 was associated with NASH (Specificity: 100% and Sensitivity: 54.3%.

Fibrosis correlated with age (r = 0.37; p = 0.027), AST (r = 0.5; p = 0.002), and HOMA-IR (r = 0.45; p = 0.007).

In multiple lineal regression, the only factor associated with fibrosis was the HOMA-IR (R = 0.60; p = 0.0001). All of the patients with advanced fibrosis (F3-F4) showed a HOMA-IR index >4.5, but only 8/26 (30%) patients with F0-F2; p < 0.001.

Conclusions: Insulin resistance is present in the majority of the patients with non-alcoholic fatty liver disease. HOMA-IR index >4.5 or triglyceride levels >180 mg/dl are predictors of the presence of NASH. Insulin resistance may play a role in the pathogenesis of fibrosis progression in patients with NAFLD. Drugs able to decrease insulin resistance could be useful in the therapy of this disease.


Total Calories May Contribute to Development of Fatty Liver

“LIVER STEATOSIS (Fatty Liver) IN OPEN POPULATION: PREVALENCE AND RELATIONSHIP TO THE DIET. PRELIMINARY RESULTS OF THE ``ARSITA-ONE'' PROJECT”

I. Petridis1, E. Lattanzi1, B. Marraccini1, I. Carderi1, E. Claar1, C. Liani1, S. Lobello1, O. Di Andrea2, M. Chiaramonte1

1 Hepato-Gastroenterology and Nutrition Unit - Dept. of Internal Medicine and Public Health - L'Aquila University, L'Aquila, Italy
2 Arsita Family Doctor, Italy


Background and Aim: This study, part of a larger epidemiological study for liver and metabolic diseases carried out on Arsita (Abruzzo) (805 adult registered inhabitants), was designed: 1) to assess the prevalence of liver steatosis; 2) to evaluate the relationship with the diet.

Materials and Methods: All subjects aged over 18 yr were invited to have liver ultrasound (US) and an alimentary questionnaire computer analyzed (Winfood 1.5). Liver steatosis was classified as none, mild, moderate and severe. Diet was classified as: diet 1, a traditional local diet, hypercaloric (3500-4500 kcal), hyperlipidic (55% of calories); diet 2, similar but with less calories (2500-3500 kcal); diet 3, classic Mediterranean (2000-2500 kcal).

RESULTS
--
541 subjects (253 M and 288 F), completed the US and diet study.
--Moderate/severe steatosis was found in 89/253 (35%) males and 75/288 (26%) females; in 41/164 (25%) subjects under 40 yr, in 63/119 (33%) subjects aged 40-59 yrs and in 92/196 (47%) subjects over 60 yr.
--143/253 males (57.5%) and 86/288 females (30%) followed diet 1, which was related to obesity (BMI > 30) in 61% of males and 69% of females, while 14% of subjects having diet 2 were obese.

--All subjects with mediterranean diet had normal BMI.
--In diet 1 group, 71.5% of males and 64.5% of females had steatosis, while in diet 2 this was respectively 25.1% and 31.3%.
--In subjects with steatosis, alcohol consumption was present in 82% of males and in 48% of females, while BMI > 30 was present in 61% of males and 78% of females.
--Out of 164 subjects with steatosis 22 (13%) had altered AST and/or ALT (13 anti-HCV+).

Conclusions: Prevalence of steatosis is increasing with age and is more frequent in males. In females severe steatosis is mainly correlated with overweight and in males with alcohol abuse. The amount of total calories instead of the proportion of fat seems to be related to liver steatosis. Elderly people had moderate/severe in 47%, however in most cases steatosis is indolent. Hepato cytolisis, without virus, seems to be very rare. Liver steatosis without ``a second hit'' seems to be a benign condition.


#11732 From: John Barrow <pozbod@...>
Date: Fri Apr 29, 2005 1:55 pm
Subject: Bristol Meyers Squibb for the side effects of Zerit?
johnftl59
Offline Offline
Send Email Send Email
 
While they might not have reacted with "lightning speed," and I think
some of their reaction was "not in the right place,"  I think the
chances of winning such a lawsuit are slim to none.

Zerit was viewed as a God send to hoards of people with HIV who were
terrified of AZT.    If Viread/Tenofavir gets much more bad press, I
would not hesitate to return to Zerit.   I'd much rather have
lipoatrophy than renal failure, thank you very much.

As unfortunate as the experience we have each had with side effects,
any court would look at the alternative of not having meds at all.


JB
On Apr 29, 2005, at 9:44 AM, PozHealth@yahoogroups.com wrote:

> Has anyone heard if there are any class action lawsuits filed against
> Bristol Meyers Squibb for the side effects of Zerit?
>
> I would guess that the Company new way in advance of the lipodystrophy
> associated with its drug.  They should have warned the consumer or
> pulled the drug from the market.
>
> Maybe if there was a lawsuit, we could recover some of the money spend
> on trying to restore our bodies.

#11731 From: "Michael Mooney" <mmooney@...>
Date: Fri Apr 29, 2005 2:14 pm
Subject: Vitamin C does not cause kidney stones
michaelmoone...
Offline Offline
Send Email Send Email
 
Whatever the cause of your kidney stones, it was not Vitamin C.
Studies show reduced kidney stones with more Vitamin C (and B6).

The cause of kidney stones is usually too much oxalic acid in the body, or
too little calcium in the GI tract to bind to oxalic acid to carry it out -
so it does not enter the body. As much as 99 percent of kidney stones can be
calcium oxalate, calcium bonded to oxalic acid. Some studies indicate that
having enough calcium in the diet or via supplementation to reduce oxalic
acid intake can help reduce the potential for kidney stone formation, too.

********************************************************************
Higher Doses of Vitamin C Have Been Shown To Decrease Kidney Stones And
Increase Bone Density

Gerster, H. No contribution of ascorbic acid to renal calcium oxalate
stones. Ann Nutr Metab 1997;41(5):269-282

Comment: For those who are concerned that Vitamin C intake might increase
the risk of kidney stones, this study stated that, "In the large-scale
Harvard Prospective Health Professional Follow-Up Study, those groups in the
highest quintile of Vitamin C intake, above 1,500 mg per day, had a lower
risk of kidney stones than the groups in the lowest quintiles."

Side note:
Vitamin C also increases bone density when enough is taken.

Morton DJ, et al.  Vitamin C supplement use and bone mineral density in
postmenopausal women. J Bone Min Res 2001;16(1):135-140.
Comment: This study showed that senior women who took between 1,000 and
5,000 mg of supplemental Vitamin C per day had approximately 5% greater
spinal bone mineral density than women who took 500 mg or less over three
years. Higher Vitamin C doses were superior to 500 mg per day or less.

Michael Mooney

***********************************************************************

Message: 4
    Date: Wed, 27 Apr 2005 11:50:43 -0700
    From: <frankjacks@...>
Subject: RE: hEllooooooooooooooooooeveryone

I'd be cautious about heavy-dosing vitamin C. I found out (the hard way)
that it is a major cause of kidney stones, and such pain
you don't want to know. As always, TALK TO YOUR DOCTOR before you do
anything!

#11730 From: JuLev@...
Date: Fri Apr 29, 2005 10:41 am
Subject: NATAP: new PK data on Lexiva-Nexium, Tenofovir
JuLev@...
Send Email Send Email
 
NATAP - http://www.natap.org

GSK Reports new PK Data on Fosamprenavir (Lexiva)

PK Data on Lexiva-Tenofovir & Lexiva-Nexium

Reported by Jules Levin

GlaxoSmithKline distributed this information by Press release this morning, which was presented the Pharmacology Workshop ongoing in Quebec. I extracted the important information to read. NATAP is covering the Pharmacology Workshop & will be providing expert reporting & commentary following the meeting.

Lexiva/r co-administration with the NRTI tenofovir did not result in a significant difference in plasma APV PK when the two agents were dosed once daily in fasted healthy volunteers.

No significant safety findings in the 35 men studied when combining TDF with LEXIVA/r QD.

LEXIVA offers flexible dosing and no food or fluid restrictions, which may simplify ART regimens for some patients.

This study was a prospective, crossover study of 35 male volunteers.  All subjects took LEXIVA/r alone and in combination with TDF 300mg once daily in a fasted state.  One cohort took LEXIVA 1400mg/ritonavir 200mg once daily and the other cohort took LEXIVA 1400mg/ritonavir 100mg once daily.  After 14 days, a 24-hour PK profile was measured.

Specific results:

o     No relevant effects of TDF on plasma amprenavir (APV) PK were demonstrated when once daily TDF 300mg was given in combination with once daily LEXIVA/r 1400/100 or 1400/200.

o     There were no grade III-IV adverse events in any study group.

-     Today GlaxoSmithKline (GSK) presented new pharmacokinetic (PK) data on taking the HIV protease inhibitor LEXIVA (fosamprenavir calcium, FPV) Tablets with the proton pump inhibitor (PPI), Nexium (esomeprazole magnesium, ESO) 20mg Delayed-Release Capsules. When these agents were simultaneously co-administered there was no effect on amprenavir steady-state plasma levels.  Current prescribing information in the U.S. for LEXIVA states that LEXIVA should be used with caution when co-administered with proton pump inhibitors as it may be less effective due to decreased amprenavir concentrations in patients taking these agents concomitantly. GSK performed an interaction study to determine if the simultaneous co-administration of esomeprazole alters the pharmacokinetics of LEXIVA.  PPIs such as esomeprazole, are potent inhibitors of the gastric acid pump and are often taken for the prevention and treatment of heartburn and other symptoms of gastroesophageal reflux disease (GERD).  The study findings of APV10031, a randomized, open-label crossover study, were presented at the 6th International Workshop on Clinical Pharmacology of HIV Therapy in Quebec, Canada.

When Lexiva was simultaneously co-administered with Nexium there was no effect on amprenavir (the active molecule LEXIVA) steady-state plasma levels.

Current prescribing information in the U.S. for LEXIVA states that LEXIVA should be used with caution when co-administered with PPIs as it may be less effective due to decreased amprenavir concentrations in patients taking these agents.

“GERD is a common condition with up to 20 percent of the U.S. adult population reporting symptoms associated with chronic heartburn, and up to 40 percent of adults suffering from heartburn at least once a month” commented Benjamin Young, M.D., and Ph.D., attending physician in infectious diseases at Rose Medical Center, Denver.

The APV10031 study was a crossover study in 48 healthy adult volunteers in the following three treatment periods: 

1.     All subjects received 20mg of the PPI ESO once-a-day (QD) for seven days.
2.     Immediately thereafter, subjects received 20mg of ESO QD with either 1,400mg of LEXIVA twice-a-day (BID) or 700mg of LEXIVA plus 100mg of RTV BID for 14 days. 
3.     Following a washout period of 21-28 days, subjects received 1400mg LEXIVA BID or 700mg of LEXIVA plus 100mg of RTV for 14 days. 

PK parameters from each combination of drugs were compared to each drug alone.

Based on the results, the authors concluded that simultaneous co-administration of 20mg ESO QD with either LEXIVA or LEXIVA/r had no effect on steady state plasma APV PK.

Specific results:

For all plasma APV parameters compared (AUC, Cmax, and Cmin), no significant differences were found when LEXIVA or LEXIVA/r were given simultaneously with ESO. ESO AUC and Cmax were unchanged when dosed in combination with LEXIVA/r, whereas ESO dosed in combination with LEXIVA increased ESO AUC by 55 percent and Cmax was unchanged, according to the study's authors.






#11729 From: <frankjacks@...>
Date: Fri Apr 29, 2005 4:15 am
Subject: RE: Help me to be a better nurse
frankcjackson
Offline Offline
Send Email Send Email
 

Be a human being at all cost. You’re going to run into quite a few people who will only complain about how bad they feel or hurt or how afraid they are. Hold their hand. Help them feel comfortable. I’ve watched hundreds of friends die over the last 25 years. It isn’t pretty and it can be very, very lonely and painful. No matter how bad your day has been, theirs has probably been worse. Do what you can to lessen their pain – both physical and emotional.

 

Frank C. Jackson

San Francisco

 


From: PozHealth@yahoogroups.com [mailto:PozHealth@yahoogroups.com] On Behalf Of C Collins
Sent: Thursday, April 28, 2005 10:49 AM
To: PozHealth@yahoogroups.com
Subject: [PozHealth] Help me to be a better nurse

 

Hi. My name is CC and I am a nursing student due to graduate in August.
As part of this semester I am to give a presentation on HIV.  I would
like to
focus on "how to be a better nurse to the HIV patient.".  Is there
anything you would like to tell a graduating group of nurses? Any of
your thoughts or advice is greatly appreciated! My project is due
05/02/05 so an immediate response would be much obliged!
Please email me at  skibabet@...











Welcome to our PozHealth group!
If you received this email from someone who forwarded it to you and would like to join this group, send a blank email to PozHealth-subscribe@yahoogroups.com and you will get an email with instructions to follow. You can chose to receive single emails or a daily digest (collection of emails). You can post pictures, images, attach files and search by keyword old postings in the group.

For those of you who are members already and want to switch from single emails to digest or vice versa, visit www.yahoogroups.com, click on PozHealth, then on "edit my membership" and go down to your selection. The list administrator does not process any requests, so this is a do-it-yourself easy process ! :)
Thanks for joining. You will learn and share a lot in this group!

NOTE: I moderate, approve or disapprove emails before they are posted. Please follow the guidelines shown in the homepage. I will not allow rudeness, sexually  explicit material, attacks, and anyone who does not follow the rules. If you are not OK with this, please do not join the group.

Forward this email to anyone who may benefit from this information! Thanks!
In Health,

Nelson Vergel (PoWeRTX@...)
List Founder and Moderator




#11728 From: Albenson@...
Date: Fri Apr 29, 2005 9:49 am
Subject: Anemia and low Testosterone Linked in Patients With HIV Infection
Albenson@...
Send Email Send Email
 
 

Anemia and low Testosterone Linked in Patients With HIV Infection

Posted By Al Benson

From (registration restricted) MedScape Medical News

HIV-infected men who have low levels of testosterone appear to be at increased risk of anemia, according to the results of a cross-sectional, observational study.

"These findings, while they do not prove causality, suggest a link between low testosterone levels and anemia in patients with HIV," lead investigator Dr. Caroline Behler told Reuters Health.

Dr. Behler and colleagues at the University of California-San Francisco evaluated 200 HIV-positive patients attending a public hospital HIV clinic between July 2000 and August 2001. The subjects, which included 161 men, 38 women, and 1 male-to-female transgender subject, completed questionnaires and underwent laboratory testing.

Overall, 24% of the women and 28% of the men were anemic, Dr. Behler's group reports in the March issue of AIDS Research and Human Retroviruses. After adjusting the data for confounding factors, being female was negatively associated with anemia (odds ratio, 0.30) as was current antiretroviral therapy (odds ratio, 0.43) and current androgen use (odds ratio, 0.20).

Among factors positively associated with anemia, were lymphopenia (odds ratio, 4.0), high erythropoietin levels (odds ratio, 7.73) and low testosterone levels (odds ratio, 3.27).

Given these findings, concluded Dr. Behler, "it would be interesting to study prospectively the effects of androgen supplementation on hemoglobin levels and quality of life in HIV-positive individuals with low testosterone levels."

AIDS Res Hum Retroviruses 2005;21:200-206.


#11727 From: John Barrow <pozbod@...>
Date: Fri Apr 29, 2005 2:02 pm
Subject: i have never had allergies,
johnftl59
Offline Offline
Send Email Send Email
 
Don,

It does sound very much like allergies.  Have you had any changes in T
cells, up or down in the last few months?  Sometimes, improving immune
function leads to allergic manefestations you didn't have before.
Allergies also tend to increase with age, and we're getting older......

JB
On Apr 29, 2005, at 9:44 AM, PozHealth@yahoogroups.com wrote:

> i have never had allergies,
> but i imagine this is what they would be like.  i have seen an eye
> doctor but
> they have nothing specific to say about this and i never thought to
> mention the
> medication change.  anyways, i have tried to figure out what could be
> happening as nothing has changed in my medical/medication life other
> than that small
> change in med formulation.  it is a puzzle.  could it be HIV related?
> that
> seems weird, but i guess the second name of this disease is "weird".

#11726 From: RAMB46@...
Date: Fri Apr 29, 2005 9:41 am
Subject: Fuzeon question?
RAMB46@...
Send Email Send Email
 
Good morning everyone,
  I will be starting a new regimen on Monday May 1st.
I will be on : Reyataz, Norvir, Truvada, & Fuzeon.
 I do not have any body fat, & I  know the Fuzeon causes injection site reactions.
Does anyone have some tips that will help when you are injecting Fuzeon ?
 I am really concerned how to TRY to help avoid problems ,if possible.
 I have become resistent to all classes of meds, except ' PI's & Tenofovir, this is why I have to start with Fuzeon & PI's.
 Hope someone is on this type of HAART, & can help me out.
Does Reyataz also cause Lipodystrophy ?
 I already have a lot of visceral fat in my abdomen, & hope this does not get worse.
Any information would greatly be appreciated,
         Thanks,
 
Ron
New England, Ma.

#11725 From: PoWeRTX@...
Date: Fri Apr 29, 2005 9:36 am
Subject: Will a Pill a Day Prevent HIV? Anticipating the Results of the Tenofovir "Prep"
nelsonvergel
Offline Offline
Send Email Send Email
 
From  AVAC (link from hepatitisandhiv.com)

Will a Pill a Day Prevent HIV? Anticipating the Results of the Tenofovir "Prep" Trials
Research is currently taking place that could change the way we think about preventing HIV infection. Tenofovir (Viread), a drug that is now widely used in treatment of HIV and AIDS, is being tested in Africa, Asia, and the Americas for possible use as a product that HIV-negative people could take regularly to reduce their risk of HIV infection. This potential application of tenofovir is called pre-exposure prophylaxis - or "PREP". No drug has yet been licensed for PREP. Full Article - 4/29/05
 
*******************
I am transitioning to a new email : nvergel@...
so please feel free to answer to this one if you are having problems with my AOL email. Thanks!


Nelson Vergel
Director
Program for Wellness Restoration, PoWeR
A 501 (c) 3 non profit national organization
powerusa.org
salvagetherapies.org
faciawasting.org


Disclaimer

This information (and any accompanying printed material) is not intended to replace the attention or advice of a physician or other health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a qualified health care professional.

#11724 From: PoWeRTX@...
Date: Thu Apr 28, 2005 11:48 pm
Subject: Exercise Enhancement and Risk Precautions
nelsonvergel
Offline Offline
Send Email Send Email
 

Exercise Enhancement and Risk Precautions

It is better to prepare than to repair. Knowing this, it is important to incorporate some form of exercise into your weekly routine. Moderate exercise on a consistent basis can make a significant improvement in your mental and physical health.

To achieve the national health objective for increasing leisure-time physical activity, comprehensive public health efforts are needed to improve reported levels of leisure-time physical inactivity for all population groups for all months of the year. Examples of strategies and approaches to increase leisure-time physical activity include encouragement to climb stairs and to avoid the use of labor-saving devices (Blamey et al. 1995).

Physical inactivity increases the risk of many chronic disorders such as diabetes, obesity, cardiovascular disease, and many types of cancers. Studies have proven that maintaining moderate levels of physical activity (e.g., brisk walking 3 hours a week) greatly reduces the incidence of developing many chronic health conditions (Chakravarthy et al. 2002). Despite these findings, approximately one-third of adults in the United States report no leisure-time physical activity, and the prevalence of leisure-time physical inactivity is highest among those who are older (MMWR 2002).

Physical activity does not need to be excessive or overbearing (as in over - training). Sometimes less is better: Doing things in moderation and pacing yourself is important. Although we know the important benefits of regular physical exercise, there are certain downsides on the molecular affects that overexertion places on the body in the short- and long-term. This protocol will enlighten the physically active enthusiast about how to enhance the effects of exercise, protect against negative effects, and increase energy levels, so that you will have more productive workouts. If you are physically inactive, you may be encouraged to begin even a modest exercise regimen.

The Many Upsides of Exercise

There are many studies documenting the fact that engaging in consistent exercise on a regular basis can have a significant impact on how long one will live. Exercise will also improve the quality of that life. Although exercise throughout life is optimal, studies have shown that as little as two sessions of training a week can increase muscle strength and muscle volume by more than 30% in aged people (Lacour et al. 2002).

In older Americans who are not physically fit and who do not exercise regularly, regular physical exercise can increase the body's metabolism and make it more efficient in burning calories. Physical fitness also makes respiration more efficient. Evidence suggests strongly that physically fit people live 2-3 years longer and have a better quality of life than sedentary individuals. Anytime is the best time for a person of any age to start exercising. Exercise is movement: dancing, walking, lifting a weight, and using the body. Physicians who prescribe exercise should help the patients create programs that are interesting, fun, and geared toward their individual needs. Strategies include the stages of change model, individualized behavioral therapy, and an active lifestyle. Exercise should be geared toward strength training, aerobic exercise, and balance and flexibility. Physicians can help motivate their patients to participate in exercise by recommending exercises that are fun, straightforward, and geared toward the individual's needs. By providing proper motivation, more patients will comply (Nied et al. 2002).

Along with a good diet and supplement regimen, regular exercise can:

  • Help build healthy bones and muscles
  • Improve strength and endurance
  • Reduce body fat and help to control weight
  • Reduce anxiety, stress, and improve mood state
  • Improve blood pressure and cholesterol
  • Slow down negative cognitive changes that may accompany aging
  • Improve the immune system
  • Greatly improve glucose metabolism and insulin sensitivity

Many studies have shown exercise to improve mental acuity in the old and the young. (Venjatraman et al. 1997; Nieman et al. 1999). Studies have shown that exercise can increase brain-derived neurotrophic factor (BDNF), which enhances synaptic plasticity and neuron functions of the brain and growth factors, stimulates neurogenesis, increases resistance to brain insults, and improves learning and mental performance. Therefore, exercise is not just important for our bodies, but also our minds (Neeper et al. 1996; Berchtold et al. 2002; Cotman et al. 2002).

The Downside

Like most things in life, there is always a downside to any upside, and exercise is no exception. Although the benefits of exercise clearly outweigh the risks, we must acknowledge the potential downsides and look for ways to minimize them. Although moderate exercise has been shown to improve immunity, extreme and prolonged exercise has been shown to suppress the immune system (Fitzgerald 1991). This is commonly called overtraining syndrome (OTS) and is common with athletes who train too long and too hard.

A study reported in the Review of Environmental Health showed that various parameters that measure immune response were actually suppressed during vigorous and prolonged heavy exercise. The researchers found that phagocyte activation, suppressed NK-cell function, impaired lymphocyte proliferation, decreased in vitro immunoglobulin production, and activation of pro - inflammatory cytokines to be present in active muscle of individuals engaged in various forms of heavy exercise. The researchers concluded that average athletes should take the antioxidant vitamins C and E and nonsteroidal anti-inflammatory drugs (NSAIDs) for muscle inflammation (Shepard et al. 1996).

One study found that a group of runners who trained for a marathon, but did not compete, were much less likely to get upper respiratory infections than the runners who completed the race, demonstrating how much such endeavors can take out of a person. The old saying "too much of a good thing can be bad " rings true with exercise also. Long-term repetitive and impactive exercise is also associated with cartilage degeneration, and that is the last thing people, especially older people, need (Nieman 1999).

One well-known effect of exercise is that it raises oxidative stress and increases free radical production. Although exercise has been shown to improve antioxidant mechanisms, these defenses can be overwhelmed over time. The risk of increased free radical production, including damage to DNA and a host of pathologies, is best avoided. The issue of free radical production and oxidative stress is made more important when we factor in our various lifestyles and environment. For example, it has been shown that ozone greatly increases oxidative stress and is made even worse when we exercise in areas with high ozone levels (Mudway et al. 1999; Corradi et al. 2002).

Most major cities, and many rural areas surrounding major cities, have highly elevated ozone levels at certain times of the year, and people are told not to exercise at peak ozone times. Poor diet, smoking, certain drugs, and other lifestyle factors greatly increase oxidative stress. Therefore, exercise combined with poor lifestyle habits could do more harm than good, although most studies do not show that effect as much as one would expect. In other words, of all the terrible things a person can do to themselves on a daily basis, exercise still appears to be a positive rather than a negative in improving overall health.

The trick is to make exercise work for you. That is, to have the highest benefit with the lowest risk, incorporate the proper nutrients into your daily life that are specific to the issues of exercise raised above.

Nutrients for Athletes
or Weekend Warriors

No matter whether you are a casual exercise buff or a serious athlete of any age, there are nutrients you can take to prevent the problems mentioned above, improve the effects of exercise, and to improve performance. For example, although it is prudent to avoid exercise at high ozone times of the day in places known to have ozone problems, even small amounts of ozone are known to affect lung function and oxidative stress. As just about everyone knows by now, antioxidants are the treatment of choice for combating free radicals and oxidative stress.

Preventing Oxidative Stress
Studies have confirmed the toxic effects of ozone on lung function and yet more studies have found adding antioxidants reduces the power of ozone to damage lung tissue. Even the simple addition of vitamins C and E to the diet of trained cyclists was shown to improve lung function. Dutch researchers gave 500 mg of vitamin C and 100 mg of vitamin E to well-trained cyclists, and another group took a placebo (using a classic double-blind placebo protocol, neither the researchers nor the athletes knew who was getting the antioxidant vitamins). The researchers found that even small amounts of ozone affected the athletes' lung functions and the addition of the antioxidants greatly reduced the negative effect of ozone on lung function of the athletes. It is well-known that the lungs are particularly sensitive to oxidative stress. The researchers theorized that the vitamins may protect the lungs against some of the effects of ozone by reducing the lung's inflammatory response to air pollution (Grievink et al. 1999).

If the simple addition of vitamin C and E can have this effect, imagine what other antioxidants or antioxidant-supporting nutrients such as N-acetyl-cysteine (NAC), whey protein, bioflavonoids, and so forth, can do. Clearly, a good all-around antioxidant-rich multivitamin formula is a must for people engaged in exercise, and the additional intake of vitamin C, E, selenium, NAC, and whey protein is highly recommended both pre- and post - workout.

Of course, antioxidants have many functions in addition to combating ozone damage such as improving immunity, a concern to athletes who may suffer from OTS. Whey protein has been shown to improve the specific areas of the immune system depleted by intense exercise. In particular, several studies have shown whey protein increases glutathione, the body's most important water-soluble antioxidant that is essential to immunity (Micke et al. 2001).

Preventing Mineral Depletion and Improving Joint Health
Studies have shown exercise increases the use and excretion of minerals. Mineral status is particularly important to older individuals, and a good mineral supplement containing highly bioavailable forms of calcium, magnesium, potassium, and boron combined with a good diet is recommended (Clarkson et al. 1995). Of course, healthy joints are needed to exercise or to be functional throughout life for that matter. Nutrients known to improve joint health/function, such as glucosamine and chondroitin, SAMe, hydrolyzed gelatin, omega-3 fatty acids, GLA, and antioxidants can be added into the diet of people who exercise and are concerned about joint health. These nutrients are particularly helpful to active people who already have joint problems they wish to address.

Reducing Inflammation
Natural supplements have been shown to decrease the systemic inflammation that is found in many disease states and that may accompany sustained physical activity. Vitamin K helps reduce levels of IL-6, a pro-inflammatory messenger. Vitamin K also helps in the treatment of osteoporosis by regulating calcium and promoting bone calcification, a factor that is also important for athletes. The docosahexaenoic acid (DHA), a fraction of fish oil is the best documented supplement to suppress TNF-alpha, IL-6, IL-1(b), and LTB(4). Studies on healthy humans and those with rheumatoid disease show that fish oil suppresses these dangerous cytokines by up to 90% (Khalfoun et al. 1997; Weber 1997). Chronic inflammation can also be mediated via diet modification. Foods that may contribute to chronic inflammation are foods with a high glycemic index (things that digest quickly), such as fruit juices or rice cakes, foods heavy in polyunsaturated or saturated fats, and foods high in arachidonic acid, such as red meat. Arachidonic acid is a precursor to both prostaglandin E2 and the pro - inflammatory cytokine leukotriene B (Kreisberg et al. 1983; Pajari et al. 1998).

Performance

The subject of enhancing athletic performance could very well be the most confusing and controversial section of this protocol. There is an extensive, virtually endless list of nutrients claimed to improve athletic performance. We will address some of the more well-known supplements here, and their effectiveness in improving athletic performance.

Maintaining Mitochondrial Health
Many of the supplements on the market reported to increase performance do improve overall health, but have not been substantiated to improve athletic scores. For example, although alpha-lipoic acid, L-carnitine, and c C oenzyme Q10 (CoQ10) have been pushed as performance enhancers by some companies, none of them has any convincing research to show any effects on performance. The importance of CoQ10, alpha-lipoic acid, and carnitine, however, lies in their ability to prevent age-related mitochondrial exhaustion. Intense exercise generates lots of free radicals that are especially damaging to the mitochondria. This means that athletes and active people should supplement with at least 100 mg a day of CoQ10, 1000 mg a day of L-carnitine or acetyl-L-carnitine, and 250 mg a day of alpha-lipoic acid.

A few studies suggest that antioxidants can improve performance, although others show no benefits. Yet, as previously stated, many supplements that are lacking in data showing that they improve performance are clearly good for you and should not be overlooked. However, taking these supplements may not necessarily make you run faster or lift more weight (Vargiu et al. 2002).

One supplement that has been shown to increase strength and lean body mass is creatine monohydrate. Some studies show clear-cut performance enhancement from creatine, although some do not. The general consensus is that creatine is best for activities that require explosive short duration activities, such as weight lifting or sprinting, but some endurance athletes do feel they benefit from using creatine even though the research has been contradictory on that point (Preen et al. 2001; Cox et al. 2002).

Creatine
One supplement that has been shown to increase strength and lean body mass is creatine monohydrate. Some studies show clear-cut performance enhancement from creatine, although some do not. The general consensus is that creatine is best for activities that require explosive short duration activities, such as weight lifting or sprinting, but some endurance athletes do feel they benefit from using creatine even though the research has been contradictory on that point (Preen et al. 2001; Cox et al. 2002).

Creatine may also have several crossover uses into health other beneficial uses. Several studies have confirmed it appears to lower s cholesterol levels by up to 15% by unknown mechanisms. Just as promising, several studies suggest creatine can be helpful in diseases that attack the neuromuscular system (Wallimann et al. 1998). Several researchers are already making recommendations for using creatine with such diseases. Creatine and several creatine derivatives may also be useful in certain pathologies of the heart in which energy production of the heart muscles are affected. Creatine may also be beneficial for those afflicted with certain diseases that cause muscle wasting (such as amyotrophic lateral sclerosis ALS), but more research is needed for any definitive recommendations to be made (Klivenyi et al. 1999; Mazzini et al. 2001). Studies have also shown that creatine may improve exercise performance and metabolism (Romer et al. 2001; Volek et al. 2001; Yquel et al. 2002). Although creatine has been shown to be an exceptionally safe supplement in all the research studies to date, it may not be appropriate for everyone. People with impaired kidney function might be wise to avoid creatine supplements at this time.

Whey Protein
Whey protein has been the protein supplement of choice for athletes and active people and for good reason. Although performance would probably not be affected by the simple addition of whey to a person's diet, active people, certain athletes, and older individuals are known to require additional protein. Considering that whey has the highest biological value of any protein yet studied and offers additional health benefits, it is no wonder it is the number one selling protein supplement on the sports market. Whey is a true crossover product. Although it has become a staple for most athletes, its confirmed ability to prevent cancer in animals, increase immunity, raise glutathione levels, and possibly retain muscle mass makes it a true health product in its own right. People would be wise to see it that way.

Thermogenic Compounds
One of the perhaps more controversial supplements, ephedrine/caffeine (EC) mixture, has been shown to improve performance in several ways. Athletes and active people like to take an EC mixture prior to exercising for increased energy levels. There is also no doubt that it improves fat loss when a person is on a reduced calorie diet, and studies that looked at the combination show it clearly helps to reduce body fat while preserving muscle mass (Astrup et al. 1992a; 1992b). Some studies suggest that the addition of aspirin to the EC combo enhances the thermogenic effect, however, a head-to-head comparison has yet to be done.

Although the potential side effects of the EC products have been greatly overstated by the "don't confuse us with the facts" media, EC products are not for everyone. Studies have shown the side effects to be usually mild, transient, and short-lived (Greenway 2001). Because EC products and pseudoephedrine are stimulants, anyone with high blood pressure, persons using MAO inhibitors, pregnant women, and men with benign prostate enlargement are warned to not use EC products. at this time. It is also important not to take more than 16 mg of ephedrine and 40 mg of caffeine in any one dose before exercise. As already mentioned, persons with hypertension should not take any EC product before heavy exercise. Pseudoephedrine is now available in place of ephedrine.

The proper use of natural thermogenic compounds, such as ephedrine , pseudoephrine, and caffeine, may be as an energy "pick-me-up" prior to exercise or as an adjuvant during a weight-loss program. However, t T hese compounds should be used prudently and are not for everyone, although the research to date has shown them to be quite generally safe (Boozer et al. 2002; Kalman et al. 2002). It is important to understand that L l osing weight using EC products is a gradual process that takes about 3 weeks of moderate dosing in order for the body to start burning significant body fat.

Ephedrine has currently been replaced by pseudoephedrine in the over-the-counter market. Ephedrine is still naturally available in herbal products such as Ma Huang.

Exercise has its ups and downs. The key to making it exercise work for you is to understand the benefits that lifelong exercise can offer, and evaluate the many options available to those looking for a supplement regimen that may help offset the risks involved with such activities. The following supplements can help protect the body against the adverse effects of exercise and improve performance.

  1. A multinutrient formula called Life Extension Mix provides optimal potencies of N-acetyl-cysteine, bioflavonoids, vitamins E and C, and magnesium, along with other nutrients that can help protect against excess production of free radicals generated during exercise. The suggested dose is 3 tablets three times a day.
  2. In addition to Life Extension Mix, 1 capsule a day of Gamma E Tocopherol/Tocotrienols should be taken to provide the critical gamma form of vitamin E need ed to balance the alpha form contained in Life Extension Mix.
  3. Enhanced Whey Protein (with added lactoferrin) is an immune booster, which helps to increase glutathione levels and enhance antioxidant action, as well as will provide the additional protein that is needed for physical exertion and endurance, 2-4 scoops daily for athletes and body builders. Each scoop supplies about 20 grams of whey protein isolate.
  4. To improve joint health and function, the following supplements may be taken:
    • Glucosamine/Chondroitin 500/500-mg capsules, 2-8 capsules daily
    • SAMe, one 400-mg tablet daily
  5. Essential fatty acids will help protect joints by lowering levels of damaging inflammation. Super GLA/DHA contains a balanced formula of gamma-linolenic acid (GLA), docosahexaenoic acid (DHA), and eicosapentaenoi n c acid (EPA); 6 softgels daily are recommended.
  6. Vitamin K helps reduce inflammation and promotes bone health; one 10-mg Super K softgel daily.
  7. Essential trace minerals are often lost during strenuous exercise. While Life Extension Mix provides most of these minerals, it would be advisable to supplement with 1000-1500 mg of elemental calcium. This could be accomplished by supplementing with 5 capsules a day of calcium citrate.
  8. The following supplements will enhance mitochondrial energy:
    • CoQ10, 100-200 mg daily
    • L-carnitine (or acetyl-L-carnitine), 1000-2000 mg daily
    • Alpha-lipoic acid, 250-500 mg daily
  9. Creatine monohydrate in micronized form is recommended in maintenance doses of 2-5 grams a day. Athletes sometimes take 10 grams a day of creatine before explosive exercise of short duration. (Avoid creatine NGH if there is kidney impairment.)
 
*******************
I am transitioning to a new email : nvergel@...
so please feel free to answer to this one if you are having problems with my AOL email. Thanks!


Nelson Vergel
Director
Program for Wellness Restoration, PoWeR
A 501 (c) 3 non profit national organization
powerusa.org
salvagetherapies.org
faciawasting.org


Disclaimer

This information (and any accompanying printed material) is not intended to replace the attention or advice of a physician or other health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a qualified health care professional.

Messages 11724 - 11753 of 31307   Newest  |  < Newer  |  Older >  |  Oldest
Advanced
Add to My Yahoo!      XML What's This?

Copyright 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help